 Intracerebral hemorrhage cerebral infarction subdural hematoma acute myocardial infarction thrombolytic therapy Thrombolysis Myocardial Infarction Study Thrombolysis Myocardial Infarction Phase II pilot clinical trial Thrombolysis Myocardial Infarction Phase II pilot clinical trial patients pilot study randomized study mg recombinant tissue-type plasminogen rt-PA activator combination heparin aspirin patients pilot study randomized study mg rt-PA combination heparin aspirin Adverse neurological events patients mg rt-PA cerebral infarctions intracerebral hemorrhages subdural hematomas patients mg rt-PA cerebral infarctions intracerebral hemorrhages subdural hematomas difference adverse neurological events rt-PA regimens due frequency intracerebral bleeding patients mg rt-PA Patients recent months histories stroke eligible study patients history cerebrovascular disease ineligible early study small number patients history neurological disease intermittent cerebral ischemic attacks stroke stricter eligibility criteria basis incomplete baseline information increased frequency intracerebral hemorrhage patients histories Mortality weeks presentation patients intracerebral hemorrhage Intracerebral hemorrhage severe infrequent complication rt-PA therapy acute myocardial infarction combined frequency intracerebral hemorrhage subdural hematoma cerebral infarction treatment mg rt-PA comparable trials thrombolytic agents acute myocardial infarction